{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:25:13Z","timestamp":1794029113361,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Excellent Young Scientists Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070655"],"award-info":[{"award-number":["82070655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000605"],"award-info":[{"award-number":["82000605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.metabol.2023.155774","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:17:41Z","timestamp":1704514661000},"page":"155774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPAR\u03b1-mediated CYP7A1 activation"],"prefix":"10.1016","volume":"152","author":[{"given":"Zhenmei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhe","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2023.155774_bb0005","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","volume":"2","author":"Lammert","year":"2016","journal-title":"Gallstones Nat Rev Dis Primer"},{"issue":"9531","key":"10.1016\/j.metabol.2023.155774_bb0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet Lond Engl"},{"issue":"9","key":"10.1016\/j.metabol.2023.155774_bb0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/bjs\/znac154","article-title":"Tailoring diagnosis and treatment in symptomatic gallstone disease","volume":"109","author":"Latenstein","year":"2022","journal-title":"Br J Surg"},{"issue":"9","key":"10.1016\/j.metabol.2023.155774_bb0020","first-page":"148","article-title":"The treatment of gallstone disease","volume":"117","author":"Gutt","year":"2020","journal-title":"Dtsch Arzteblatt Int"},{"key":"10.1016\/j.metabol.2023.155774_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijsu.2020.07.017","article-title":"Trauma of major surgery: a global problem that is not going away","volume":"81","author":"Dobson","year":"2020","journal-title":"Int J Surg Lond Engl"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/SLA.0000000000003791","article-title":"Safe cholecystectomy multi-society practice guideline and state of the art consensus conference on prevention of bile duct injury during cholecystectomy","volume":"272","author":"Brunt","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.metabol.2023.155774_bb0035","article-title":"Recent advances, novel targets and treatments for cholelithiasis; a narrative review","volume":"908","author":"S","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.metabol.2023.155774_bb0040","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/biom12040550","article-title":"Factors influencing gallstone formation: a review of the literature","volume":"12","author":"Sun","year":"2022","journal-title":"Biomolecules"},{"issue":"5 Suppl","key":"10.1016\/j.metabol.2023.155774_bb0045","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1002\/hep.1840040806","article-title":"Biliary lipid secretion in health and in cholesterol gallstone disease","volume":"4","author":"Carey","year":"1984","journal-title":"Hepatol Baltim Md."},{"issue":"3","key":"10.1016\/j.metabol.2023.155774_bb0050","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1194\/jlr.S091199","article-title":"Gallbladder bile supersaturated with cholesterol in gallstone patients preferentially develops from shortage of bile acids","volume":"60","author":"Rudling","year":"2019","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2023.155774_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.723918","article-title":"Circadian rhythm disruption influenced hepatic lipid metabolism, gut microbiota and promoted cholesterol gallstone formation in mice","volume":"12","author":"He","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2023.155774_bb0060","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2020.0636","article-title":"Hypothyroidism increases cholesterol gallstone prevalence in mice by elevated hydrophobicity of primary bile acids","author":"Kube","year":"2021","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.metabol.2023.155774_bb0070","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.cmet.2021.09.001","article-title":"Cholesterol-induced toxicity: an integrated view of the role of cholesterol in multiple diseases","volume":"33","author":"Song","year":"2021","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.metabol.2023.155774_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00518-22","article-title":"FXR signaling-mediated bile acid metabolism is critical for alleviation of cholesterol gallstones by lactobacillus strains","volume":"10","author":"Ye","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.metabol.2023.155774_bb0080","doi-asserted-by":"crossref","first-page":"30215","DOI":"10.1038\/srep30215","article-title":"Osteopontin deficiency alters biliary homeostasis and protects against gallstone formation","volume":"6","author":"Lin","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2023.155774_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154728","article-title":"Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity","volume":"118","author":"Zhang","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155774_bb0090","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/ncomms5573","article-title":"PPAR\u03b1-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2023.155774_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118405","article-title":"Palmatine regulates bile acid cycle metabolism and maintains intestinal flora balance to maintain stable intestinal barrier","volume":"262","author":"Ning","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.metabol.2023.155774_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113380","article-title":"Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia","volume":"264","author":"Xiao","year":"2021","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"10.1016\/j.metabol.2023.155774_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1499-3872(11)60029-5","article-title":"Pravastatin activates PPARalpha\/PPARgamma expression in the liver and gallbladder epithelium of hamsters","volume":"10","author":"Dong","year":"2011","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1499-3872(14)60009-6","article-title":"Pravastatin activates the expression of farnesoid X receptor and liver X receptor alpha in Hep3B cells","volume":"13","author":"Byun","year":"2014","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT."},{"issue":"3","key":"10.1016\/j.metabol.2023.155774_bb0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1210\/endrev\/bnab035","article-title":"The multifaceted biology of PCSK9","volume":"43","author":"Seidah","year":"2022","journal-title":"Endocr Rev"},{"issue":"16","key":"10.1016\/j.metabol.2023.155774_bb0120","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.metabol.2023.155774_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1194\/jlr.RA119000419","article-title":"Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice","volume":"61","author":"Pouwer","year":"2020","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.metabol.2023.155774_bb0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2020.05.027","article-title":"Efficacy and safety of Alirocumab in adults with homozygous familial hypercholesterolemia: the ODYSSEY HoFH trial","volume":"76","author":"Blom","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.metabol.2023.155774_bb0135","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab804","article-title":"Alirocumab after acute coronary syndrome in patients with a history of heart failure","volume":"43","author":"White","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.metabol.2023.155774_bb0140","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2007.03.196","article-title":"Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression","volume":"357","author":"Nilsson","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jhep.2012.08.013","article-title":"Low-density lipoprotein cholesterol and risk of gallstone disease: a Mendelian randomization study and meta-analyses","volume":"58","author":"Stender","year":"2013","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155774_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/joim.12594","article-title":"Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III","volume":"281","author":"Ghosh Laskar","year":"2017","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0168-8278(03)00177-6","article-title":"Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients","volume":"39","author":"van Erpecum","year":"2003","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.metabol.2023.155774_bb0160","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Md","year":"2018","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.metabol.2023.155774_bb0165","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.118.037184","article-title":"Lipoprotein(a), PCSK9 inhibition, and cardiovascular risk","volume":"139","author":"O\u2019Donoghue","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2023.155774_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155774_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.metabol.2019.02.002","article-title":"Role of PCSK9 in lipid metabolic disorders and ovarian dysfunction in polycystic ovary syndrome","volume":"94","author":"Wang","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155774_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155610","article-title":"Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation","volume":"145","author":"Xia","year":"2023","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.metabol.2023.155774_bb0185","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1194\/jlr.M038331","article-title":"Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression","volume":"54","author":"Parker","year":"2013","journal-title":"J Lipid Res"},{"issue":"11","key":"10.1016\/j.metabol.2023.155774_bb0190","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1194\/jlr.M051664","article-title":"Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans","volume":"55","author":"Bonde","year":"2014","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.metabol.2023.155774_bb0195","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/joim.12599","article-title":"Acute caloric restriction counteracts hepatic bile acid and cholesterol deficiency in morbid obesity","volume":"281","author":"Straniero","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2023.155774_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jsbmb.2016.10.003","article-title":"Bile acid synthesis precursors in subjects with genetic hypercholesterolemia negative for LDLR\/APOB\/PCSK9\/APOE mutations. Association with lipids and carotid atherosclerosis","volume":"169","author":"Baila-Rueda","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"17","key":"10.1016\/j.metabol.2023.155774_bb0205","doi-asserted-by":"crossref","first-page":"12530","DOI":"10.1074\/jbc.275.17.12530","article-title":"The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha","volume":"275","author":"Cheema","year":"2000","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2023.155774_bb0210","doi-asserted-by":"crossref","first-page":"R733","DOI":"10.1152\/ajpregu.00153.2019","article-title":"Loss of hepatic PPAR\u03b1 promotes inflammation and serum hyperlipidemia in diet-induced obesity","volume":"317","author":"Stec","year":"2019","journal-title":"Am J Physiol - Regul Integr Comp Physiol"},{"issue":"4","key":"10.1016\/j.metabol.2023.155774_bb0215","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s43440-019-00043-8","article-title":"Therapeutic action against chronic cholestatic liver injury by low-dose fenofibrate involves anti-chemotaxis via JNK-AP1-CCL2\/CXCL2 signaling","volume":"72","author":"Dai","year":"2020","journal-title":"Pharmacol Rep PR"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11010-020-03826-3","article-title":"NPC1L1 and ABCG5\/8 induction explain synergistic fecal cholesterol excretion in Ob\/Ob mice co-treated with PPAR-\u03b1 and LXR agonists","volume":"473","author":"Srivastava","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0225","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41467-022-28240-9","article-title":"Caffeine blocks SREBP2-induced hepatic PCSK9 expression to enhance LDLR-mediated cholesterol clearance","volume":"13","author":"Lebeau","year":"2022","journal-title":"Nat Commun"},{"issue":"7839","key":"10.1016\/j.metabol.2023.155774_bb0230","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.metabol.2023.155774_bb0235","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0240","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor \u03b1-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatol Baltim Md"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0245","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPAR\u03b1 nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.metabol.2023.155774_bb0250","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2017.01.001","article-title":"Activation of the hypoxia inducible factor 1\u03b1 subunit pathway in steatotic liver contributes to formation of cholesterol gallstones","volume":"152","author":"Asai","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12967-019-1943-y","article-title":"Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine","volume":"17","author":"Choi","year":"2019","journal-title":"J Transl Med"},{"issue":"9911","key":"10.1016\/j.metabol.2023.155774_bb0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.metabol.2023.155774_bb0265","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/s41467-020-17029-3","article-title":"Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing","volume":"11","author":"Wei","year":"2020","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2023.155774_bb0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11010-015-2590-0","article-title":"Up-regulation of liver Pcsk9 gene expression as a possible cause of hypercholesterolemia in experimental chronic renal failure","volume":"411","author":"Sucajtys-Szulc","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2023.155774_bb0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2016.02.027","article-title":"Up-regulation of Hnf1\u03b1 gene expression in the liver of rats with experimentally induced chronic renal failure - a possible link between circulating PCSK9 and triacylglycerol concentrations","volume":"248","author":"Sucajtys-Szulc","year":"2016","journal-title":"Atherosclerosis"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523003785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:15:32Z","timestamp":1777425332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049523003785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"alternative-id":["S0026049523003785"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155774","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPAR\u03b1-mediated CYP7A1 activation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155774"}}